Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
J. vasc. bras ; 19: e20200072, 2020. tab, graf
Article in English | LILACS | ID: biblio-1143212

ABSTRACT

Abstract The current coronavirus pandemic has already taken a great toll globally, causing massive morbidity and mortality. One of its severe forms is a thrombophilic state that can damage several systems. This article reports the case of 60-year-old female patient who presented with mild flu symptoms, which turned out to be a SARS-CoV2 infection, and ended up developing arterial thrombosis with limb ischemia in a private care hospital in Sorocaba, São Paulo, Brazil. Considering this progression, we decided to intervene with low molecular weight heparin and Alprostadil, achieving a good clinical outcome. Our description aims to identify key points and clinical signs that offer evidence of the therapeutic window and a treatment option for coagulatory presentations of COVID-19.


Resumo A atual pandemia de coronavírus já gerou danos profundos ao redor do mundo, causando grande quantidade de morbidades e mortes. Uma das manifestações das formas graves da doença é o estado trombofílico, que pode provocar danos em vários sistemas. Este artigo relata o caso de uma paciente do sexo feminino, 60 anos de idade, que foi internada em um serviço hospitalar privado com sintomas gripais inespecíficos leves, mas que progrediu com trombose arterial e isquemia de membros causada pelo SARS-CoV2. Devido à essa evolução, foi optada pela administração concomitante de heparina de baixo peso molecular e Alprostadil, com bom desfecho clínico. Nossa descrição objetiva identificar pontos-chave e sinais clínicos que evidenciem essa janela terapêutica, bem como uma opção de tratamento para as apresentações coagulatórias da COVID-19.


Subject(s)
Humans , Female , Middle Aged , Alprostadil/therapeutic use , Heparin/therapeutic use , COVID-19/complications , Chronic Limb-Threatening Ischemia/drug therapy , Thromboembolism/etiology , Thromboembolism/drug therapy , Thrombosis/etiology , Thrombosis/drug therapy , Chronic Limb-Threatening Ischemia/etiology
2.
Rev. Col. Bras. Cir ; 47: e20202469, 2020. tab, graf
Article in Portuguese | LILACS | ID: biblio-1136599

ABSTRACT

RESUMO Objetivo: O objetivo deste estudo foi avaliar o impacto da reabilitação peniana na recuperação da função erétil em pacientes submetidos a ressecção anterior do reto (RAR) ou a prostatectomia radical (PR), comparando os resultados entre esses dois grupos. Materiais e Métodos: Foi realizado estudo de coorte retrospetivo unicêntrico, em pacientes avaliados na nossa consulta multidisciplinar de oncosexologia, entre janeiro de 2015 e janeiro de 2018, submetidos a PR ou RAR (homens) com disfunção sexual. Avaliamos as características oncológicas dos pacientes, idade, estado civil, tipo de disfunção sexual, Índice Internacional de Função Erétil (IIEF-5) na primeira e última consulta e terapêutica utilizada. Foi realizada análise estatística. Resultados: Foram incluídos 55 pacientes, 60% (33) realizaram RAR e 40% (22) PR. Em relação à disfunção sexual após a cirurgia, a disfunção erétil (DE) foi encontrada na maioria dos pacientes (> 95%). Na pontuação inicial do IIEF-5, os pacientes com RAR e PR apresentaram, com maior frequência, DE moderada ou grave (escore 5-11), em 78,8% e 59,1% dos casos, respetivamente. Ao reavaliar a pontuação do IIEF-5 de cada paciente durante o acompanhamento, verificou-se melhoria em 69,7% dos pacientes com RAR e 72,7% dos pacientes com PR (p = 0,81). Quanto à abordagem terapêutica, 84,8% dos pacientes com RAR foram medicados com inibidores da fosfodiesterase-5 (PDE5I) exclusivamente e 3% com injeção de Alprostadil. Os pacientes com PR foram medicados com PDE5I em 63,6% e com injeção de Alprostadil em 31,8% (p <0,05). Conclusões: Apesar das diferenças técnicas destas cirurgias, do ponto de vista sexual, os pacientes se beneficiaram com a reabilitação peniana.


ABSTRACT Purpose: The aim of this study was to evaluate the impact of penile rehabilitation in restoring erectile function in patients submitted to anterior resection of the rectum (ARR) or radical prostatectomy (RP), comparing the results between these two groups. Materials and Methods: We performed a unicenter retrospective cohort study, on patients evaluated in our multidisciplinary oncosexology consultation, between January 2015 and January 2018, submitted to RP or ARR (males) and presenting sexual dysfunction. We evaluate the patient and oncologic characteristics, the type of sexual dysfunction, marital status, assessed the International Index of Erectile Function (IIEF-5) on the first and last consultation and the therapeutic approach. A statistical analysis was performed. Results: A total of 55 patients were included, 60% (33) performed ARR and 40% (22) RP. Regarding the sexual dysfunction after surgery, erectile dysfunction (ED) was found in the majority of patients (>95%). On the initial IIEF-5 scoring, ARR and RP patients had, most frequently, severe or moderate ED (score 5-11), 78.8% and 59.1% respectively. When reassessed the IIEF-5 scoring of each patient during follow-up, there was an improvement in 69.7% of ARR patients and 72.7% of RP patients (p=0.81). Regarding the therapeutic approach, 84.8% of ARR patients used phosphodiesterase-5 inhibitors (PDE5I) exclusively, 3% used Alprostadil injection, while RP patients used 63.6% and 31.8%, respectively (p<0.05). Conclusions: Despite the technical differences of these surgeries, from the sexual point of view these patients benefit with a penile rehabilitation.


Subject(s)
Humans , Male , Adult , Aged , Prostatectomy/methods , Prostatic Neoplasms/surgery , Alprostadil/therapeutic use , Phosphodiesterase 5 Inhibitors/therapeutic use , Erectile Dysfunction/rehabilitation , Prostatectomy/adverse effects , Rectum , Penile Erection/drug effects , Retrospective Studies , Urological Agents/therapeutic use , Erectile Dysfunction/etiology , Middle Aged
3.
Int. braz. j. urol ; 44(3): 617-622, May-June 2018. graf
Article in English | LILACS | ID: biblio-954058

ABSTRACT

ABSTRACT Objective: To investigate the effect of papaverine and alprostadil on testicular torsion-detorsion injury in rats. Materials and Methods: A total of 40 male Wistar-Albino rats were used in this study. Four hours of right testicular torsion was applied to each group, excluding sham oper- ated group. The torsion-detorsion (T/D), T/D + papaverine and T/D + alprostadil groups received saline, papaverine and alprostadil at the same time as surgical detorsion, respectively. At 14 days after the surgical detorsion, ischaemic changes and the degree of damage were evaluated with Cosentino scoring and the Johnson tubular biopsy score (JTBS). Results: JTBS was determined as 8.8±2.7 in the Sham group, 5.08±1.9 in the T/D+papaverine group, 5.29±2.3 in the T/D +alprostadil group and 2.86±1.9 in the TD group. The JTBS was determined to be statistically significantly high in both the T/D + papaverine group and the T/D + alprostadil group compared to the T/D group (p=0.01, p=0.009). In the T/D + papaverine group, 3 (43%) testes were classified as Cosentino 2, 3 (43%) as Cosentino 3 and 1 (14%) as Cosentino 4. In the T/D +alprostadil group, 5 (50 %) testes were classified as Cosentino 2, 3 (30 %) as Cosentino 3 and 2 (20%) as Cosentino 4. Conclusion: The present study indicated that spermatic cord administration of alprostadil and papaverine showed a protective effect against ischemia/reperfusion injury after right-side testes torsion and histological changes were decreased after testicular ischemia reperfusion injury.


Subject(s)
Animals , Male , Papaverine/therapeutic use , Spermatic Cord Torsion/prevention & control , Testis/blood supply , Vasodilator Agents/pharmacology , Alprostadil/pharmacology , Ischemia/prevention & control , Papaverine/pharmacology , Spermatic Cord Torsion/pathology , Testis/pathology , Vasodilator Agents/therapeutic use , Biopsy , Severity of Illness Index , Alprostadil/therapeutic use , Reperfusion Injury/prevention & control , Random Allocation , Reproducibility of Results , Treatment Outcome , Rats, Wistar , Protective Agents/therapeutic use , Protective Agents/pharmacology
4.
Rev. Assoc. Med. Bras. (1992) ; 63(5): 422-426, May 2017. tab, graf
Article in English | LILACS | ID: biblio-896345

ABSTRACT

Summary Introduction: In systemic sclerosis (SSc), digital ulcers (DU) are debilitating and recurrent. They are markers of prognosis and are associated with disability and mortality. Treatment strategies have been developed to block the proposed mechanisms of this complication. Objective: Clinical description of a population of SSc patients with DU, treatment, complications and outcome. Method: Analysis of 48 SSc patients meeting 2013 ACR-EULAR criteria, followed between 1999-2015; 13 patients had DU. Treatment protocol applied included cycles of 21 days of alprostadil, which can be repeated in the absence of DU healing. After DU healing, bosentan was initiated. Results: DU healing was achieved with intravenous prostanoid in 12 patients; seven patients required repeated treatment for DU healing. Twelve patients were later treated with bosentan; three of them experienced recurrence of DU, while one was anti-B2-GPI positive. Four patients had soft tissue loss and three other suffered digital amputation, these being late diagnosis. Conclusion: Younger patients and early referrals had better outcomes. Endothelin receptor antagonist toxicity should be monitored, particularly in patients previously exposed to hepatotoxic drugs.


Resumo Introdução: As úlceras digitais (UD) são complicações incapacitantes e recorrentes, associadas a menor qualidade de vida e maior mortalidade na esclerose sistêmica (ES). O tratamento baseia-se em antagonizar os mecanismos fisiopatológicos em causa. Objetivo: Descrever uma amostra de doentes com diagnóstico de ES e UD, o tratamento, as complicações e os resultados clínicos. Método: Série de 48 casos diagnosticados com ES, critérios de classificação ACR-EULAR 2013, seguidos entre 1999 e 2015, dos quais 13 apresentavam UD. O protocolo aplicado incluía ciclos de 21 dias de alprostadil podendo ser repetidos no caso de não existir cicatrização. Nos casos em que houve cicatrização foi iniciado bosentano. Resultados: No tratamento das UD, 12 doentes realizaram prostaciclina endovenosa, com necessidade de tratamentos repetidos em sete doentes. Doze doentes foram posteriormente tratados com bosentano, com recorrência de UD em três doentes, um deles com presença de anti-B2-GPI. Quatro doentes ficaram com cicatrizes e em três houve amputação digital, sendo casos de diagnóstico tardio. Conclusão: Os doentes mais jovens tiveram melhores resultados, possivelmente em razão de melhorias globais nos cuidados de saúde prestados e de referenciação precoce. A toxicidade dos antagonistas dos receptores da endotelina deve ser monitorizada, sobretudo em doentes com exposição prévia a drogas hepatotóxicas.


Subject(s)
Humans , Male , Female , Aged , Aged, 80 and over , Scleroderma, Systemic/complications , Skin Ulcer/etiology , Skin Ulcer/drug therapy , Sulfonamides/therapeutic use , Vasodilator Agents/therapeutic use , Alprostadil/therapeutic use , Fingers , Endothelin Receptor Antagonists/therapeutic use , Skin Ulcer/pathology , Time Factors , Wound Healing/drug effects , Reproducibility of Results , Treatment Outcome , Dose-Response Relationship, Drug , Bosentan , Hand Dermatoses/etiology , Hand Dermatoses/pathology , Hand Dermatoses/drug therapy , Middle Aged
5.
Braz. j. med. biol. res ; 50(8): e6185, 2017. tab, graf
Article in English | LILACS | ID: biblio-888975

ABSTRACT

Ischemia/reperfusion injury is still a major cause of morbidity and mortality during liver surgery and transplantation. A variety of surgical and pharmacological therapeutic strategies have been investigated to minimize the effects of ischemia/reperfusion. The aim of our study was to analyze and compare preventive influences of ischemic preconditioning, adenosine and prostaglandin E1 in the experimental model of hepatic ischemia/reperfusion injury. Adult chinchilla rabbits were divided into four groups: 10 rabbits subjected to liver ischemic preconditioning (3-min period of inflow occlusion followed by a 5-min period of reperfusion) followed by 45 min of Pringle maneuver; 10 rabbits subjected to pre-treatment with intraportal injection of adenosine followed by 45 min of Pringle maneuver; 10 rabbits subjected to pre-treatment with intraportal injection of prostaglandin E1 followed by 45 min of Pringle maneuver; and control group of 10 rabbits subjected to 45 min of inflow liver ischemia without any preconditioning. On the second postoperative day, blood samples were obtained and biochemical parameters of liver function were measured and compared. Liver tissue samples were also obtained and histopathological changes were compared. Based on biochemical and histopathological parameters, it was demonstrated that ischemic preconditioning provided the best protection against hepatic ischemia/reperfusion injury. This was probably due to a wider range of mechanisms of action of this method oriented to reduce oxidative stress and inflammation, and restore liver microcirculation and hepatocyte energy compared to the examined pharmacological strategies.


Subject(s)
Animals , Male , Female , Adenosine/therapeutic use , Alprostadil/therapeutic use , Ischemic Preconditioning/methods , Liver Diseases/prevention & control , Liver/blood supply , Reperfusion Injury/prevention & control , Chinchilla , Disease Models, Animal , Liver/drug effects , Liver/pathology
6.
Korean Journal of Urology ; : 99-108, 2015.
Article in English | WPRIM | ID: wpr-217670

ABSTRACT

Although disease-free survival remains the primary goal of prostate cancer treatment, erectile dysfunction (ED) remains a common complication that affects the quality of life. Even though several preventive and therapeutic strategies are available for ED after radical prostatectomy (RP), no specific recommendations have been made on the optimal rehabilitation or treatment strategy. Several treatment options are available, including phosphodiesterase-5 inhibitors, vacuum erection devices, intracavernosal or intraurethral prostaglandin injections, and penile prostheses. Urologists must consider more effective ways to establish optimal treatments for ED after RP. ED is an important issue among patients with prostate cancer, and many patients hope for early ED recovery after surgery. This review highlights the currently available treatment options for ED after RP and discusses the limitations of each.


Subject(s)
Humans , Male , Alprostadil/therapeutic use , Erectile Dysfunction/etiology , Penile Implantation , Phosphodiesterase 5 Inhibitors/therapeutic use , Prostatectomy/adverse effects , Prostatic Neoplasms/surgery , Risk Factors , Vacuum , Vasodilator Agents/therapeutic use
7.
Yonsei Medical Journal ; : 999-1005, 2013.
Article in English | WPRIM | ID: wpr-121788

ABSTRACT

PURPOSE: The pathological mechanism of lumbar spinal stenosis is reduced blood flow in nerve roots and degeneration of nerve roots. Exercise and prostaglandin E1 is used for patients with peripheral arterial disease to increase capillary flow around the main artery and improve symptoms; however, the ankle-brachial index (ABI), an estimation of blood flow in the main artery in the leg, does not change after treatment. Lumbar spinal nerve roots contain somatosensory, somatomotor, and unmyelinated autonomic nerves. Improved blood flow by medication with prostaglandin E1 and decompression surgery in these spinal nerve roots may improve the function of nerve fibers innervating muscle, capillary, and main vessels in the lower leg, resulting in an increased ABI. The purpose of the study was to examine whether these treatments can improve ABI. MATERIALS AND METHODS: One hundred and seven patients who received conservative treatment such as exercise and medication (n=56) or surgical treatment (n=51) were included. Low back pain and leg pain scores, walking distance, and ABI were measured before treatment and after 3 months of conservative treatment alone or surgical treatment followed by conservative treatment. RESULTS: Low back pain, leg pain, and walking distance significantly improved after both treatments (p<0.05). ABI significantly increased in each group (p<0.05). CONCLUSION: This is the first investigation of changes in ABI after treatment in patients with lumbar spinal stenosis. Improvement of the spinal nerve roots by medication and decompression surgery may improve the supply of blood flow to the lower leg in patients with lumbar spinal stenosis.


Subject(s)
Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Alprostadil/therapeutic use , Ankle Brachial Index , Decompression, Surgical/methods , Low Back Pain/drug therapy , Lumbar Vertebrae/physiopathology , Pain/surgery , Spinal Nerve Roots/physiopathology , Spinal Stenosis/physiopathology , Treatment Outcome
8.
In. Atik, Edmar; Moreira, Valéria de Melo Moreira. Imagens e correlações em cardiologia pediátrica: diagnóstico e terapêutica em casos clínicos. São Paulo, Roca, 2011. p.24-85.
Monography in Portuguese | LILACS | ID: lil-594762
9.
Journal of Korean Medical Science ; : 897-903, 2006.
Article in English | WPRIM | ID: wpr-98119

ABSTRACT

Studies investigating the effect of prophylactic drugs on hepatic veno-occlusive disease (VOD) development are rare in children that have undergone allogeneic hematopoietic stem cell transplantation (HSCT). This study examined risk factors for VOD, the effect of prophylactic low-dose heparin or lipo-prostaglandin E1 (lipo-PGE1) and the survival rate at day +100 in children undergoing allogeneic HSCT. Eighty five children underwent HSCT between June 1997 and September 2004. Patients were diagnosed and classified as having mild, moderate or severe VOD according to Seattle clinical criteria. Among 85 patients, 25 (29%) developed VOD. VOD occurred more frequently in patients receiving busulfan-based conditioning (24/65, 37%) than in those receiving TBI-based (1/10, 10%) or other (0/10, 0%) regimens (p<0.05). The incidence of VOD was lower in patients with non-malignant disease compared to those with malignant disease (p<0.05). Survival at day +100 for non-VOD patients was better than that for VOD patients (92% vs. 76%, p<0.05). No patients receiving prophylactic heparin or lipo-PGE1 were found to develop severe VOD, whereas 5 of 35 patients not receiving such prophylaxis developed severe VOD. Given severe VOD is associated with a high mortality rate, this study indicates that prophylactic heparin or lipo-PGE1 may decrease mortality in children undergoing HSCT.


Subject(s)
Male , Infant , Humans , Female , Child, Preschool , Child , Adult , Adolescent , Risk Factors , Hepatic Veno-Occlusive Disease/etiology , Heparin/therapeutic use , Hematopoietic Stem Cell Transplantation/adverse effects , Alprostadil/therapeutic use
10.
Journal of Korean Medical Science ; : 371-373, 2006.
Article in English | WPRIM | ID: wpr-12243

ABSTRACT

Cutaneous polyarteritis nodosa (CPAN) is an uncommon form of vasculitis involving small and medium sized arteries of unknown etiology. The disease can be differentiated from polyarteritis nodosa by its limitation to the skin and lack of progression to visceral involvement. The characteristic manifestations are subcutaneous nodule, livedo reticularis, and ulceration, mostly localized on the lower extremity. Arthralgia, myalgia, peripheral neuropathy, and constitutional symptoms such as fever and malaise may also be present. We describe a 34-yr-old woman presented with severe ischemic change of the fingertip and subcutaneous nodules without systemic manifestations as an unusual initial manifestation of CPAN. Therapy with corticosteroid and alprostadil induce a moderate improvement of skin lesions. However, necrosis of the finger got worse and the finger was amputated.


Subject(s)
Humans , Female , Adult , Vasodilator Agents/therapeutic use , Skin Diseases, Vascular/complications , Polyarteritis Nodosa/complications , Gangrene/etiology , Fingers , Amputation, Surgical , Alprostadil/therapeutic use , Adrenal Cortex Hormones/therapeutic use
11.
Rev. invest. clín ; 52(4): 432-40, jul.-ago. 2000. ilus, CD-ROM
Article in Spanish | LILACS | ID: lil-294960

ABSTRACT

La disfunción eréctil es un padecimiento con alta prevalencia asociada a enfermedades crónicas primordialmente del sistema cardiovascular. El mejor conocimiento de la fisiología ha permitido desarrollar nuevos fármacos que permiten ofrecer opciones terapéuticas apropiadas para cada tipo de paciente. Se vislumbra un panorama de creciente investigación básica y clínica que seguramente redundarán en mejores tratamientos para esta enfermedad. Esta revisión pretende hacer un resumen de los conceptos fisiológicos modernos y aplicarlos a un mejor entendimiento de los medicamentos disponibles actualmente.


Subject(s)
Penile Erection/physiology , Erectile Dysfunction/drug therapy , Erectile Dysfunction/therapy , Alprostadil/therapeutic use , Phentolamine/therapeutic use , Phosphodiesterase Inhibitors/therapeutic use
12.
Rev. venez. urol ; 44(1): 25-7, ene.-jun. 1997.
Article in Spanish | LILACS | ID: lil-228320

ABSTRACT

La disfunción sexual eréctil es una enfermedad de etiología multifactorial que depende básicamente de la edad del paciente y de la existencia de enfermedades asociadas. Su importancia radica en que afecta al 1,9 por ciento de los hombres a los 40 años y al 25 por ciento a los 65 años de edad. actualmente existen varias formas de tratarla siendo una de ellas la utilización de drogas intracavernosas. En este trabajo se evalúa la eficacia y tolerancia del alprostadil (PGE) como droga intracavernosa para el tratamiento de la disfunción sexual eréctil (DSE). Se incluyeron 20 pacientes con DSE de origen psicógeno, neurogénico o vascular, con edad promedio de 46,5 años (rango 20-65 años) y una evaluación de 30,5 meses en promedio. Se utilizaron dosis progresivas hasta un máximo de 40 mg a intervalos de una semana hasta lograr una respuesta. Esta fue considerada como ausente, parcial o total, se registraron la presión arterial y los efectos adversos. Obtuvimos un 70 por ciento de respuesta positivas a la droga y un 30 por ciento de respuestas negativas o no satisfactorias. Esta experiencia nos permite concluir que la PGE1, es una droga eficaz y bien tolerada en el tratamiento de la disfunción sexual eréctil


Subject(s)
Humans , Male , Alprostadil/therapeutic use , Sexual Dysfunctions, Psychological/therapy
13.
J. bras. ginecol ; 106(6): 209-12, jun. 1996.
Article in Portuguese | LILACS | ID: lil-176657

ABSTRACT

Num período de cinco anos, foram estudados 331 pacientes impotentes, de etiologia desconhecida, submetidos a auto-injeção de drogas vasoativas. A solução utilizada foi associação da prostaglandina E, fentolamina e papaverina. O índice de sucesso foi de 98,7 por cento, representado pela obtenção de ereção plena, promovendo uma vida sexual satisfatória tanto para o paciente quanto para sua companheira. As complicações do tratamento foram bastante discretas, representadas por priapismo em 14 pacientes (4,28 por cento), porém correspondendo a apenas 0,04 por cento do total de aplicações realizadas durante o seguimento mediano de 29 meses. Não houve nenhum caso de fibrose dos corpos cavernosos. O índice de cura, ou seja, o retorno à atividade sexual sem qualquer forma de tratamento foi de 11,92 por cento. Noventa e oito pacientes (29,96 por cento) abandonaram o tratamento. Curiosamente, dos 98 pacientes que interromperam o tratamento por insucesso ou abandono, apenas dois (2,04 por cento) optaram por um outro tipo de tratamento, submetendo-se a implante de prótese peniana. A auto-injeção de drogas vasoativas apresenta alto índice de sucesso no tratamento da impotência de qualquer etiologia, com grande segurança e baixo índice de complicações


Subject(s)
Humans , Male , Alprostadil/therapeutic use , Penile Erection , Erectile Dysfunction/drug therapy , Injections, Subcutaneous , Papaverine/therapeutic use , Phentolamine/therapeutic use , Priapism/complications , Self Administration , Vasoconstrictor Agents/therapeutic use
14.
Actas cardiovasc ; 7(2): 100-4, 1996.
Article in Spanish | LILACS | ID: lil-235131

ABSTRACT

Objetivo: La microembolia masiva es una patología difícil de diagnosticar y tratar, grave, que con frecuencia conduce a la muerte de los pacientes. Material y métodos: Entre enero de 1993 y mayo de 1995 ingresaron 11 pacientes con diagnóstico de ateroembolismo. Diez eran hombres con edad promedio de 72 años, evaluados mediante TC y angiografía digital. Resultados: El tratamiento consistió en cirugía convencional en todos los casos, excepto en uno en el que se realizó un procedimiento endovascular. La mortalidad fue de 45 por ciento. Se hace especial hincapié en la administración de prostaglandina intra-arterial para el tratamiento de las lesiones isquémicas distales. Conclusiones: El ateroembolismo puede provenir de trombos originados en úlceras ateromatosas o de desprendimientos de fragmentos de placas de ateroma. Está compuesto por pequeños acúmulos de fibrina, plaquetas, células sanguíneas y cristales de colesterol. Estos pacientes presentan en general aortas ulceradas, friables, desflecadas e irregulares, aneurismas aórtico o ilíacos y con menor frecuencia poplíteos. Cuando comprometen a los parénquimas viscerales tienen peor pronóstico. Se relata la sistemática de diagnóstico y tratamiento quirúrgico, el tratamiento de exclusión de la circulación de la fuente embolígena sobre la aorta y el incremento de esta patología por procedimientos diagnósticos angiorradiológicos o anticoagulación sistémica


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Alprostadil/therapeutic use , Aortic Aneurysm, Abdominal/complications , Embolism and Thrombosis , Embolism/drug therapy , Peripheral Vascular Diseases , Alprostadil/administration & dosage , Alprostadil/adverse effects , Embolism/diagnosis , Embolism/etiology
15.
Rev. méd. Inst. Peru. Segur. Soc ; 4(1): 13-5, ene.-mar. 1995. tab
Article in Spanish | LILACS | ID: lil-163608

ABSTRACT

Se presenta el estudio de 113 casos de paciente tratados con Prostaglandina E-1 para evacuación uterina, realizado en el Departamento de Obstetricia del Hospital Nacional Edgardo Rebagliati Martins del Instituto Peruano de Seguridad Social, entre Enero de 1992 y Diciembre de 1993. El motivo del estudio fue la búsqueda de una alternativa al uso de la Oxitocina para la evacuación uterina, en casos en que estuviera indicado dicho procedimiento por alguna razón médica. Se utilizó la vía oral y, en ocasiones se combinó con la vía vaginal. Los resultados fueron exitosos en 103 casos y frustros en 10 (8.8 por ciento). Los efectos colaterales fueron mínimos. Su manejo por vía oral, la rara presentación de efectos secundarios y el bajo porcentaje de casos frustos, lo constituyen en producto a elegir en el diario manejo de la especialidad; su uso acorta la estancia hospitalaria; puede ser utilizado en grandes multíparas y en pacientes cesareadas anteriores; facilitando el tratamiento quirúrgico complementario.


Subject(s)
Humans , Female , Pregnancy , Alprostadil/administration & dosage , Alprostadil/therapeutic use , Uterine Contraction , Labor, Induced/adverse effects , Labor, Induced , Tocolytic Agents/administration & dosage , Tocolytic Agents/therapeutic use
16.
J. bras. med ; 67(4): 156-65, out. 1994.
Article in Portuguese | LILACS | ID: lil-163786

ABSTRACT

Desde 1970 o tratamento da impotência sexual tem sofrido inúmeras modificaçoes. Isto se deu graças ao profundo conhecimento adquirido, através de inúmeras pesquisas, da fisiofarmacologia envolvida na ereçao. A descoberta de que substâncias vasoativas injetadas dentro dos corpos cavernosos poderiam produzir uma ereçao fisiológica trouxe nova luz ao tratamento de tal moléstia. Esta nova modalidade terapêutica, doravante denominada auto-injeçao intracavernosa, é sem dúvida o tratamento de primeira escolha para o paciente com disfunçao erétil de qualquer etiologia em 1994. Neste artigo os autores descrevem as principais drogas utilizadas nesta modalidade terapêutica, assim como o seu mecanismo de açao e complicaçoes.


Subject(s)
Humans , Male , Alprostadil/therapeutic use , Erectile Dysfunction/drug therapy , Papaverine/therapeutic use , Phentolamine/therapeutic use , Alprostadil/pharmacology , Penile Erection , Injections , Papaverine/pharmacology , Phentolamine/pharmacology , Self Administration
17.
Rev. colomb. obstet. ginecol ; 44(3): 201-10, jul.-sept. 1993. tab
Article in Spanish | LILACS | ID: lil-293122

ABSTRACT

En el presente estudio se seleccionaron ochenta(80) pacientes del Departamento de Gineco-Obstetricia del Hospital Universitario San Rafael de Tunja y 20 de la ciudad de bucaramenga durante un período comprendido entre el 1§ de febrero y el 30 de septiembre de 1991, que tuvieran indicación médica u obstétrica para inducción del parto. No se hizo diferencia entre primi y multigestantes ni se tuvo en cuenta el estado del cuello para indicar el procedimiento. Se usó l prostaglandina E, intracervical en forma de tabletas de uso oral aplicadas con el tacto vaginal. La dosis utilizda fue de 1/4 de tableta como dosis única en el 83 por ciento de los pacientes. El 50 por ciento de pacientes eran primigestantes y el resto multigestantes. En el 61 por ciento el índice de Bishop fue de menos de 6. Respondieron a la inducción el 98 por ciento de las pacientes. Se redujo la duración del trabajo de parto: el promedio en primigestantes fue de 4 H 38' y en multigestantes 3H 52'. No hubo menoscabo del bienestar fetal ya que a los 5 minutos todos los recién nacidos tuvieron un Apgar igual o superior a 8/10. El procedimiento tuvo una gran aceptabilidad por parte de los pacientes


Subject(s)
Humans , Female , Pregnancy , Adult , Alprostadil/therapeutic use , Labor, Induced
18.
Rev. angiol. cir. vasc ; 1(2): 66-73, abr.-jun. 1992. tab
Article in Portuguese | LILACS | ID: lil-141176

ABSTRACT

O tratamento da impotência pela auto-injeçäo intracavernosa de Prostaglandina E1 apresenta grandes vantagens sobre outras drogas vasoativas, tais como o Cloridrato de Papaverina ou o Mesilato de Fentolamina. Com a associaçäo da abordagem psicológica específica - a terapia sexual, os resultados podem ser considerados mais positivos. Além da revisäo bibliográfica e descriçäo da metodologia do tratamento por auto-injeçäo intracavernosa associada com a terapia sexual, o presente artigo apresenta estudo com sessenta pacientes impotentes, sendo que 86 por cento destes obtiveram resultados positivos, com retorno às relaçöes sexuais e ereçöes satisfatórias. Com o adequado diagnóstico e a aliança da abordagem psicoterapêutica com a auto-injeçäo, os resultados satisfatórios tendem a apresentar melhores do que o referido pela literatura específica já existente


Subject(s)
Adult , Middle Aged , Humans , Male , Alprostadil/therapeutic use , Erectile Dysfunction/therapy , Sex Counseling , Aged, 80 and over , Alprostadil/administration & dosage , Penile Erection , Erectile Dysfunction/psychology , Injections , Self Administration
19.
Arq. bras. cardiol ; 58(2): 121-123, fev. 1992. tab, ilus
Article in Portuguese | LILACS | ID: lil-120714

ABSTRACT

Três recém-natos dentro do 1§ dia de vida, portadores de cianose, em decorrência de anomalia de Ebstein de importante repercussäo hemodinâmica, apresentavam aspecto de valva pulmonar imperfurada. Na evoluçäo clínica, verificou-se que a atresia era do tipo funcional, decorrente da baixa pressäo ventricular direita e hipertensäo no território pulmonar


Three newborn children with cyanosis due to Ebstein's anomaly of tricuspid valve with an important hemodynamic repercusssion presented features of imperforation of pulmonary valve. On the follow-up, clinical and laboratorial findings verified that pulmonary atresia was functional resulting from a combination of low right ventricular pressure and high pulmonary vascular resistance


Subject(s)
Humans , Infant, Newborn , Pulmonary Valve/abnormalities , Alprostadil/therapeutic use , Echocardiography, Doppler , Ebstein Anomaly/complications , Electrocardiography , Vectorcardiography
SELECTION OF CITATIONS
SEARCH DETAIL